DE3578125D1 - Formulierung von entzuendungshemmenden arzneimitteln. - Google Patents

Formulierung von entzuendungshemmenden arzneimitteln.

Info

Publication number
DE3578125D1
DE3578125D1 DE8585307055T DE3578125T DE3578125D1 DE 3578125 D1 DE3578125 D1 DE 3578125D1 DE 8585307055 T DE8585307055 T DE 8585307055T DE 3578125 T DE3578125 T DE 3578125T DE 3578125 D1 DE3578125 D1 DE 3578125D1
Authority
DE
Germany
Prior art keywords
guanidino
imidazolyl
thiazole
formulation
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585307055T
Other languages
English (en)
Inventor
John Lawrence Lamattina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3578125D1 publication Critical patent/DE3578125D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electron Beam Exposure (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
DE8585307055T 1984-10-11 1985-10-02 Formulierung von entzuendungshemmenden arzneimitteln. Expired - Fee Related DE3578125D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65975284A 1984-10-11 1984-10-11
US06/765,415 US4636498A (en) 1984-10-11 1985-08-15 Formulation of antiinflammatory drugs

Publications (1)

Publication Number Publication Date
DE3578125D1 true DE3578125D1 (de) 1990-07-19

Family

ID=27097890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585307055T Expired - Fee Related DE3578125D1 (de) 1984-10-11 1985-10-02 Formulierung von entzuendungshemmenden arzneimitteln.

Country Status (16)

Country Link
US (1) US4636498A (de)
EP (1) EP0178121B1 (de)
CN (1) CN1011196B (de)
AT (1) ATE53492T1 (de)
AU (1) AU558668B2 (de)
CA (1) CA1251138A (de)
DE (1) DE3578125D1 (de)
DK (1) DK165964C (de)
EG (1) EG17529A (de)
FI (1) FI853948L (de)
GR (1) GR852459B (de)
IE (1) IE58740B1 (de)
IL (1) IL76647A0 (de)
NZ (1) NZ213756A (de)
PH (1) PH21400A (de)
PT (1) PT81280B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
GB2222772B (en) * 1988-09-20 1992-05-13 Glaxo Group Ltd Pharmaceutical compositions
EP0703782A1 (de) * 1993-06-15 1996-04-03 Pfizer Inc. H2-antagonisten als immunstimulantien bei bakteriellen infektionen von rindern oder schweinen
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715112A (de) * 1966-11-21 1968-05-22
US4230717A (en) * 1978-12-29 1980-10-28 Lovelace Alan M Administrator Indomethacin-antihistamine combination for gastric ulceration control
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Also Published As

Publication number Publication date
PH21400A (en) 1987-10-15
EP0178121A3 (en) 1988-10-05
CA1251138A (en) 1989-03-14
DK463885A (da) 1986-04-12
PT81280B (pt) 1988-02-17
CN1011196B (zh) 1991-01-16
FI853948A0 (fi) 1985-10-10
NZ213756A (en) 1988-11-29
GR852459B (de) 1986-02-11
EG17529A (en) 1993-08-30
ATE53492T1 (de) 1990-06-15
EP0178121A2 (de) 1986-04-16
CN85107521A (zh) 1986-08-06
DK165964C (da) 1993-07-26
IL76647A0 (en) 1986-02-28
AU4848585A (en) 1986-05-08
DK165964B (da) 1993-02-22
IE58740B1 (en) 1993-11-03
PT81280A (en) 1985-11-01
FI853948L (fi) 1986-04-12
EP0178121B1 (de) 1990-06-13
US4636498A (en) 1987-01-13
IE852494L (en) 1987-02-15
AU558668B2 (en) 1987-02-05
DK463885D0 (da) 1985-10-10

Similar Documents

Publication Publication Date Title
IT8122675A0 (it) Mercaptoacil derivati di varie proline 4 sostituite e relative composizioni utili per il trattamento dell'ipertensione.
ES2180580T3 (es) Compuestos de oxazolilo sustituidos para el tratamiento de la inflamacion.
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
MX162676A (es) Procedimiento para la preparacion de derivados de 2-(piridilalquensulfinii.)benzimidazoles n-substituidos
ATE53376T1 (de) Entzuendungshemmende agentien.
OA07365A (fr) Nouvelles compositions pour la révélation et l'inhibition de la plaque dentaire.
IT1214671B (it) Metodo per inibire l'insorgere di sindrome da radiazioni e composizione diendotossina detossificata impiegata a tale scopo
IT8567393A0 (it) Derivati di delta 2-1,2,4-triazolin5-one e composizioni erbicide cheli contengono
DE3578125D1 (de) Formulierung von entzuendungshemmenden arzneimitteln.
DK527685D0 (da) 5-(omega-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno-(3,2-c)-pyridinderivater, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser
FI971831A0 (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
IT8422898A0 (it) Derivati di 1,4-diidropiridina e composizioni farmaceutiche che licontengono.
WO1991019475A1 (en) Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene d¿4?
IT8920994A0 (it) Nuovi derivati imidazolici ad azione inibente l'enzima trombossanosintetasi.
IT8419476A0 (it) Contengono. derivati dell'imidazolo e composizioni farmaceutiche che li
FI862001A0 (fi) Krok foer fiskande i vatten med undervattensvegetation.
IT8821386A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.
IT8821384A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee